# SK Bioscience

- Headquarters: South Korea
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Sites

| Place | Latest | Largest value | Types |
| --- | --- | --- | --- |
| Andong, South Korea | 2021-06-21 | $133.0M | expansion |

## Customers, suppliers and deals

- [Novavax](https://endata.com/companies/64232.md): customer, 1×, latest 2022-07-19

## Announcements (2)

- 2022-07-19: [SK Bioscience signs 39.4 billion won vaccine supply deal with Novavax](https://endata.com/announcements/69924-sk-bioscience-signs-39-4-billion-won-vaccine-supply-deal-with-novavax) (Contract · South Korea · $30.0M)
- 2021-06-21: [SK Bioscience to invest 150 billion won in vaccine factory expansion in Andong](https://endata.com/announcements/59219-sk-bioscience-to-invest-150-billion-won-in-vaccine-factory-expansion-in-andong) (Expansion · Andong, North Gyeongsang Province, South Korea · $133.0M · starts operating 2024)

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.